Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings in Brief: Baxter

This article was originally published in The Gray Sheet

Executive Summary

Baxter: Board approves a $500 mil. stock buyback program, subject to market conditions. The company, which currently has about 282 mil. shares outstanding, says it expects to complete the buyback within two years. Baxter also announces plans to pay its board members' retainers, annual fees, and retirement plans in Baxter stock. Shares of Baxter have been trading for about $28-29 on the New York Stock Exchange...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts